Studies have shown that some of the patients with IH have germline mutations in VEGFR-2 or tumor endothelial marker 8 (TEM8) and that such patients appear to be at risk of developing lesions [27]. This evidence concerns the gene ANTXR1 and isolated hemihyperplasia.